Pharmafile Logo
Pharmafocus logo
Advanced Search

epipen

Showing 15 posts of 32 posts found.

hero-plus

Mylan hit with fresh lawsuit over EpiPen pricing

April 4, 2017
Manufacturing and Production, Sales and Marketing Mylan, epipen, pricing

Just as it faces worldwide reports that over 80,000 of its EpiPens do not function properly and as the FDA …

News
1280px-epi-pen_1

FDA issues US-wide recall of Mylan’s EpiPen

April 3, 2017
Medical Communications, Sales and Marketing FDA, Mylan, epipen

After recent reports of around 80,000 defective EpiPen’s across Australia, New Zealand, Japan, Norway, Denmark, Finland and Ireland, the FDA …

News
kaleo

Rival to EpiPen to be made available to many for free

January 23, 2017
Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …

News
1280px-epi-pen_1

Drugstore chain CVS offers EpiPen generic for 600% cheaper

January 12, 2017
Medical Communications, Sales and Marketing CVS, Mylan, epipen

The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …

News
1280px-epi-pen_1

Mylan launches $300 generic EpiPen to calm pricing controversy

December 16, 2016
Sales and Marketing Mylan, epipen

Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …

News

Mylan to restructure and slash around 10% of workforce

December 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses

Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …

News

Mylan ducks call to testify in front of Senate

November 22, 2016
Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen

Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …

News
1280px-epi-pen_1

Mylan agrees $465m settlement over EpiPen misclassification

October 10, 2016
Business Services, Medical Communications, Sales and Marketing Heather Bresch, Mylan, Price hike, epipen

In the latest scandal in the EpiPen price hike saga, the US Department of Justice has made claims that the …

News

“Incorrect classification” of EpiPen leads to $1 billion bill for US government

October 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, Heather Bresch, Misclassification, Mylan, Price hike, classification, epipen, price, scandal

Mylan’s EpiPen woes show no sign of abating after CMS (Centers for Medicare and Medicaid Services) released figures that show …

News
1280px-epi-pen_1

Mylan’s promised half-price EpiPen not available until year’s end

October 5, 2016
Research and Development, Sales and Marketing Mylan, epipen

Consumers may have to wait until the end of the year for the half-price EpiPen, months after Mylan originally promised …

News
heather_bresch_2

Price-hiked EpiPen profits 66% higher than Mylan CEO claimed

September 27, 2016
Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen

In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …

News
heather_bresch

EpiPen CEO appears before US lawmakers to defend “sickening” price hikes

September 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen

Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …

News
hero-plus

Mylan CEO to appear before US congress over EpiPen scandal

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Hilary Clinton, Mylan, epipen

Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …

News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, BMS, Celgene, Cloud Computing, Eisai, FDA, GSK, Halaven, Novartis, Novo Nordisk, Roche, Teva, agios, epipen, rheumatoid arthritis

It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …

News
legal

Antitrust investigation launched into Mylan and the EpiPen scandal

September 7, 2016
Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal

The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023